BLACKROCK Municipal Income TRUST V.BFK.P

Primary Symbol: BFK

BlackRock Municipal Income Trust (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is to provide current income exempt from federal income taxes. Under normal market conditions, the Fund invests at least 80% of its managed assets in investments the income from which is exempt from federal income tax (except that the interest may be subject to the alternative minimum tax). The Fund may invest directly in securities or synthetically through the use of derivatives. The Fund's investment policies provide that it invests at least 80% of its total assets in investment grade quality municipal obligations issued by or on behalf of states, territories and possessions of the United States and their political subdivisions, agencies or instrumentalities, each of which pays interest that, in the opinion of bond counsel to the issuer, is excludable from gross income for federal income tax purposes. Its investment adviser is BlackRock Advisors, LLC.

NYSE:BFK - Post by User

BLACKROCK Municipal Income TRUST > At this price

<< Previous

Bullboard Posts

Next >>

Comment by quinlashon Sep 29, 2021 12:41pm

109 Views

Post# 33937330

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:At this price

"new" revenue streams will be the sales coming in from Zenabis, 48- North and Redecan

"different" revenue streams will be the royality payments made my MSOs in the United States that will be working with HEXO to use their patented technology to produce the Cannabis 2.0 products for US distribtion.

Additional "new" revenue streams will be sales within Germany once HEXO has that worked out. If HEXO opts to proceed with expansion into Poland and California like they eluded to.

Additional "new" revenue will also include the sales from that Fortune 200 partner that the CEO noted in the Canacord Interview.

Clear enough... I could try and find a crayon font if it would aid in you getting used to reading up on the stock.

All the best

Q

quinlash wrote: You can't be serious ? Read the news on their website and note when each deal closed. You will find that the Zenabis deal closed within the last QTR for the year therefore those numbers show on the year end report in Oct. The rest of the deals closed afterwards and will be on the following report in Dec.

If you are not researching you are gambling. If you are comfortable gambling then knock yourself out and gamble but the markets are much less risky if your speculation on the future price movements are based on actual research.

Q

Mukulu20 wrote: How do we know what Hexo will report sales from different avenues of revenue? Will there be any communication from Hexo that its October ER will include several additional revenue streams? That will placate the market and stop this relentless bleeding. Or you are 100% certain of this additional sales revenue reporting in the upcoming October report.